Kraig Biocraft Laboratories (OTCQB: KBLB) looking to graduate to a national market, probably NASDAQ

Kraig Biocraft Laboratories (OTCQB:KBLB)

DENVER, COLORADO, UNITED STATES, June 1, 2020 /EINPresswire.com/ -- For most, market timing is more about luck than skill, but individual companies’ potential market driving catalysts are much easier to identify.

For undervalued and underfunded junior market listings, graduating to a national market may be the most powerful move possible, which makes Kraig Biocraft Laboratories (OTCQB: KBLB) most recent move so important. Kraig Labs, the leading developer of spider silk based fibers, held its first Board of Directors meeting, in which management briefed the board on the Company’s 2020 expansion and growth plans, the Company confirmed that it’s gunning to bring its ecofriendly technology to a national exchange listing, probably within the next sixty days.

The timing of its scheduled spider silk production increases and the Company’s new “knock-in/knock-out” technology just happens to coincide with a sizzling materials market, which, according to FactSet, is the S&P 500’s second hottest sector, as it grew by 6.7%, in May 2020. Only Information Technology, at 6.8%, outperformed it, as they easily outpaced all other sectors, including Consumer Staples, which gained 1.4% for the month.

When junior listings graduate to a national exchange, access improved funding options to execute their game plan, and are in line with greater trends, we should expect results like Celsius Holdings (NASDAQ: CELH). The high flying “performance beverage” company’s zero-calorie fitness drinks have helped Celsius generate $28.2 million in most recent quarter revenues, a 95% year-over-year improvement, and generate $13 million in gross profits, up 128% from the year ago quarter.

Yes, even in this market, former junior listings, like Fennec Pharmaceuticals (NASDAQ: FENC), a specialty pharmaceutical company focused on the development of PEDMARK (a unique formulation of sodium thiosulfate ) for the prevention of platinum-induced ototoxicity from cisplatin in pediatric cancer patients, are able to raise the funds in their attempt to bring their technologies to market. In fact, Fennec’s recently completed underwritten $30,000,000 offering actually yielded $34,126,275 (before deducting the underwriting discounts and offering expenses), as the underwriters exercised the maximum number of option shares.

Connect with 24/7 Market News on social media:
https://twitter.com/247MarketNewsHQ
https://www.facebook.com/247MarketNewsHQ/

About 24/7 Market News

As a pioneer in digital financial market media, 24/7 Market News (24/7MN) is dedicated to the swift distribution of financial market news and information. 24/7 MN incorporates comprehensive corporate communications resources and tools to engage the investment community.

DISCLAIMER:
24/7 Market News (24/7MN) is a third party publisher and news dissemination service provider that produces regular sponsored and non-sponsored reports, articles, stock market blogs, and newsletters covering equities listed on the NYSE, NASDAQ and micro-cap exchanges. 24/7MN holds no investment licenses and is NOT a financial advisory firm, investment adviser, analyst, or broker-dealer and does not undertake any activities that would require such registration. 24/7MN's market updates, news alerts and corporate profiles are NOT a solicitation or recommendation to buy, sell or hold securities.

The material in this release is intended to be strictly informational and is NEVER to be construed or interpreted as research material. All readers are strongly urged to perform research and due diligence on their own and consult a licensed financial professional before considering any level of investing in stocks. All material included herein is republished content and based on publicly available information which is believed to be reliable. 24/7MN owns KBLB shares that it will sell. 24/7MN makes no representations as to the completeness, accuracy, or timeliness of the material provided and all materials are subject to change without notice. 24/7MN and/or its affiliates are not responsible for any gains or losses that result from the opinions expressed and are not liable for any investment decisions by its readers or subscribers. Investors are cautioned that they may lose all or a portion of their investment when investing in stocks.

For further information on 24/7 Market News, please go to www.247marketnews.com

Forward-Looking Statements
This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may," "future," "plan," or "planned," "will," or "should," "expected," "anticipates," "draft," "eventually," or "projected." You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company's annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and 24/7MN undertakes no obligation to update such statements

CONTACT:
24/7 Market News
Editor@247marketnews.com

24/7 Market News
24/7 Market News
+1 720-580-2740
email us here
Visit us on social media:
Facebook
Twitter